Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TMEM100 |
| Upstream (Parents) |
|---|
| (<<) IL1R1 → TMEM100 |
| (<<) DPYD → TMEM100 |
| (<<) C7 → TMEM100 |
| Downstream (Children) |
|---|
| TMEM100 → CDC37P1 (>>) |
| TMEM100 → FMO2 (>>) |
| TMEM100 → OBP2A (>>) |
| TMEM100 → FUT6 (>>) |
| TMEM100 → MGAT4C (>>) |
| TMEM100 → CAND2 (>>) |
| TMEM100 → GRIK5 (>>) |
| TMEM100 → BACH2 (>>) |
| TMEM100 → WNT2B (>>) |
| TMEM100 → PER3 (>>) |
